Receptos to Hold Third Quarter 2013 Financial Results Conference Call and Webcast
October 24, 2013 17:00 ET
|
Receptos, Inc.
SAN DIEGO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will...
Receptos to Deliver Scientific Presentations About RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
October 02, 2013 02:00 ET
|
Receptos, Inc.
SAN DIEGO, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Receptos Inc. (Nasdaq:RCPT) today announced that Company personnel will deliver two scientific poster presentations about RPC1063 at the annual meeting of...
Receptos to Present at BioCentury Newsmakers Conference
September 18, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, Sept. 18, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
Receptos Announces Issuance of Composition of Matter Patents Covering Proprietary Lead Product Candidate RPC1063
August 13, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced...
Receptos to Present at Upcoming Investor Conferences
August 08, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, Aug. 8, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
Receptos Reports Second Quarter 2013 Financial Results
August 07, 2013 16:05 ET
|
Receptos, Inc.
- Phase 2 trials of RPC1063 continue to enroll patients globally -
- Company capitalized to complete current Phase 2 trials -
- Additional Phase 1 results of RPC1063 to be presented at ECTRIMS...
Receptos to Hold Second Quarter 2013 Financial Results Conference Call and Webcast
August 01, 2013 08:01 ET
|
Receptos, Inc.
SAN DIEGO, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will...
Receptos Announces Appointment of Erle T. Mast as Director
July 22, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, July 22, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
Receptos to Present at JMP Securities Healthcare Conference
July 03, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, July 3, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...
Receptos to be Added to Russell 3000(R) Index on June 28, 2013
June 26, 2013 08:00 ET
|
Receptos, Inc.
SAN DIEGO, June 26, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...